Jubilant Pharmova profitability ratios
Per cent unless marked ×
| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
Returns | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |||||
|---|---|---|---|---|---|---|
| 6.0% | 6.0% | 14.4% | 1.4% | −1.1% | ||
| 2.8% | 2.8% | 6.9% | 0.6% | −0.6% | ||
| 7.0% | 7.0% | 8.0% | 5.5% | 2.4% | ||
| 5.3% | 5.9% | 9.1% | 2.6% | 1.1% | ||
Margins | ||||||
| 14.2% | 15.2% | 16.2% | 13.4% | 12.4% | ||
| 9.9% | 9.9% | 11.1% | 7.7% | 3.5% | ||
| — | 1.4% | 53.8% | 70.4% | — | ||
| 6.3% | 7.4% | 13.6% | 2.2% | 0.2% | ||
| 4.1% | 4.8% | 11.6% | 1.1% | −1.0% | ||
| 4.1% | 4.8% | 11.6% | 1.2% | −1.0% | ||
| −2.7% | −2.7% | −0.6% | 1.1% | −2.5% | ||
Additional | ||||||
| 35.6% | 35.3% | 14.7% | 66.8% | 596.7% | ||
| — | 20.0% | 9.5% | 109.8% | −123.4% | ||
| 6.0% | 4.8% | 13.0% | −0.1% | −2.5% | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.